phenoxybenzamide hydrochloride phenoxybenzamide hydrochloride

structural formula

• numbering system
• physical property data
• toxicological data
• ecological data
• molecular structure data
• computing chemical data
• more
  • properties and stability
  • storage method
  • synthesis method
  • purpose

numbering system

cas number:63-92-3

mdl number:mfcd00055152

einecs number:200-569-7

rtecs number:dp3750000

brn number:none

pubchem number:24277760

physical property data

1. character:white crystalline powder

2. density (g/ml,25/4℃): unsure

3. relative vapor density (g/ml,air=1): unsure

4. melting point (ºc):137.5

5. boiling point (ºc,normal pressure): uncertain

6. boiling point (ºc, 5.2kpa): unsure

7. refractive index:not sure

8. flash point (ºc): unsure

9. specific optical rotation (º): unsure

10. autoignition point or ignition temperature (ºc): unsure

11. vapor pressure (kpa,25ºc): unsure

12. 2. molar volume (m³ /mol):162.3

3. isotonic specific volume (90.2k):424.2

4. surface tension (dyne/cm):46.6

5. polarizability（10^-24cm³):22.56

compute chemical data

1. reference value for hydrophobic parameter calculation (xlogp): none

2. number of hydrogen bond donors: 1

3. number of hydrogen bond acceptors: 2

4. number of rotatable chemical bonds: 8

5. number of tautomers: none

6. topological molecule polar surface area 12.5

7. number of heavy atoms: 22

8. surface charge: 0

9. complexity: 262

10. number of isotope atoms: 0

11. determine the number of atomic stereocenters: 0

12. uncertain number of atomic stereocenters: 1

13. determine the number of chemical bond stereocenters: 0

14. number of uncertain chemical bond stereocenters: 0

15. number of covalent bond units: 2

properties and stability

none yet

storage method

this product should be sealed and stored in a cool, dry place away from light.

synthesis method

none yet

purpose

organic synthesis. medicine.
α-receptor-negative agent with strong selectivity and long-lasting effect. mainly used for pheochromocytoma, raynaud’s syndrome, cyanosis of the foot and sequelae of frostbite.

ont-family: arial; mso-hansi-font-family: arial; mso-font-kerning: 0pt; mso-bidi-font-family: arial”>organic synthesis. medicine.
α-receptor-negative agent with strong selectivity and long-lasting effect. mainly used for pheochromocytoma, raynaud’s syndrome, cyanosis of the foot and sequelae of frostbite.